Interventions for the treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis

Quality and Safety in Health Care

Volumn 11, Issue 3, 2002, Pages 284-288

  Bagnall, Anne Marie ^a   Whiting, P ^a   Richardson, R ^a   Sowden, A J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AMPLIGEN; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; ESSENTIAL FATTY ACID; FLUDROCORTISONE; FLUOXETINE; GALANTAMINE; GANCICLOVIR; HOMEOPATHIC AGENT; HUMAN GROWTH HORMONE; HYDROCORTISONE; IMMUNOGLOBULIN; IMMUNOLOGIC AGENT; INTERFERON; LEUKOCYTE EXTRACT; LIVER EXTRACT; MAGNESIUM; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SULBUTIAMINE; TERFENADINE;

ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; BLEEDING; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; COGNITIVE THERAPY; DIET SUPPLEMENTATION; DRUG INDUCED DISEASE; FOLLOW UP; HOMEOPATHY; HUMAN; INFECTION; KIDNEY FAILURE; KINESIOTHERAPY; LIVER FAILURE; MASSAGE; MEDICAL LITERATURE; OUTCOMES RESEARCH; PERICARDIUM; PHLEBITIS; PUBLICATION; RASH; REVIEW;

EID: 0036752772     PISSN: 09638172     EISSN: None     Source Type: Journal    
DOI: 10.1136/qhc.11.3.284     Document Type: Review

References (60)

1. NHS Centre for Reviews and Dissemination. Interventions for the management of CFS/ME. Effective Health Care 2002;7.
2. NHS Centre for Reviews and Dissemination. A Systematic Review of Interventions for the Treatment and Management of Chronic Fatigue Syndrome and/or Myalgic Encephalomyelitis. York: University of York (in preparation).
3. Mulrow CD, Ramirez G, Cornell JE, et al. Defining and Managing Chronic Fatigue Syndrome. Rockville, MD: Agency for Healthcare Research and Quality, 2001.
4. Whiting P, Bagnall AM, Sowden AJ, et al. Interventions for the treatment and management of chronic fatigue syndrome: A systematic review. JAMA 2001;286:1360-8.
5. Sharpe M, Archard L, Banatvala J. A report: Chronic fatigue syndrome: Guidelines for research. J R Soc Med 1991;84:118-21.
6. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
7. Holmes G, Kaplan J, Gantz N, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-9.
8. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med 1997;90:223-33.
9. Dowsett EG, Ramsay AM, McCartney RA, et al. Myalgic encephalomyelitis: A persistent enteroviral infection? Postgrad Med J 1990;66:526-30.
10. Wessely S, Hotopf M, Sharpe M. Chronic Fatigue and Its Syndromes. New York: Oxford University Press, 1999.
11. Department of Health. A Report of the CFS/ME Working Group: Report to the Chief Medical Officer of an Independent Working Group. London: Department of Health, 2002.
12. Lawrie S, Pelosi A. Chronic fatigue syndrome in the community: Prevalence and associations. Br J Psychiatry 1995;166:793-7.
13. Wessely S, Chalder T, Hirsch S, et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: A prospective primary care study. Am J Public Health 1997;87:1449-55.
14. Powell P, Edwards RHT, Bentall RP. The treatment of wheelchair-bound chronic fatigue syndrome patients: Two case studies of a pragmatic rehabilitation approach. Behav Cognitive Psychother 1999;27:249-60.
15. Essame CS, Phelan S, Aggett P, et al. Pilot study of a multidisciplinary inpatient rehabilitation of severely incapacitated patients with the chronic fatigue syndrome. J Chronic Fatigue Syndr 1998;4:51-60.
16. Chalder T, Butler S, Wessely S. In-patient treatment of chronic fatigue syndrome. Behav Cognitive Psychother 1996;24:351-65.
17. NHS Centre for Reviews and Dissemination. Cardiac rehabilitation. Effective Health Care 1998;4.
18. NHS Centre for Reviews and Dissemination. Acute and chronic low back pain. Effective Health Care 2000;6.
19. Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: A randomised controlled trial. BMJ 1996;312:22-6.
20. Deale A, Chalder T, Marks I, et al. Cognitive behavior therapy for chronic fatigue syndrome: A randomized controlled trial. Am J Psychiatry 1997;154:408-14.
21. Prins J, Bleijenberg G, Bazelmans E, et al. Cognitive behaviour therapy for chronic fatigue syndrome: A multicentre randomised controlled trial. Lancet 2001;357:841-8.
22. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: A double-blind, placebo-controlled trial. J Med 1993;94:197-203.
23. Deale A, Hussain K, Chalder T, et al. Long term outcome of cognitive behaviour therapy versus relaxation for chronic fatigue syndrome: A 5-year follow-up study. Am J Psychiatry 2000;158:2038-42.
24. O'Dowd H. Cognitive behavioural therapy (CBT) in chronic fatigue syndrome (CFS): a randomised controlled trial of o group prgramme for the primary care population. Available from: http:// www.update.software.com/nrr/CLIBINET.EXE?A=1&U=1001&P=10001 (accessed 23 April 2002).
25. Wessely S. A randomised controlled trial of CBT for CFS in primary care. Available from: http://www.update.software.com/nrr/ CLIBINET.EXE?A=1&U=1001&P=10001 (accessed 23 April 2002).
26. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997;314:1647-52.
27. Powell P, Bentall RP, Nye FJ, et al. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ 2000;322:387-92.
28. Wearden AJ, Morriss RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry 1998;172:485-92.
29. Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990;89:561-8.
30. Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990;89:554-60.
31. Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res 1997;31:133-47.
32. DuBois RE. Gamma globulin therapy for chronic mononucleosis syndrome. AIDS Res 1986;2:S191-5.
33. Vollmer Conna U, Hickie I, Hadzi Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997;103:38-43.
34. Strayer DR, Carter WA, Brodsky I, et al. A controlled clinical trial with a specifically configured RNA drug, poly(I) · poly(C-12U), in chronic fatigue syndrome. Clin Infect Dis 1994;1:S88-95.
35. Steinberg P, McNutt BE, Marshall P, et al. Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome. J Allergy Clin Immunol 1996;97:119-26.
36. Brook M, Bannister B, Weir W. Interferon-alpha therapy for patients with chronic fatigue syndrome. J Infect Dis 1993;168:791-2.
37. See DM, Tilles JG. Alpha interferon treatment of patients with chronic fatigue syndrome. Immunol Invest 1996;25:1-2.
38. Straus SE, Dale JK, Tobi M, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med 1988;319:1692-8.
39. Lerner AM, Zervos M, Chang CH, et al. A small, randomized, placebo-controlled trial of the use of antiviral therapy for patients with chronic fatigue syndrome. Clin Infect Dis 2001;32:1657-8.
40. Natelson BH, Cheu J, Pareja J, et al. Randomized, double-blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology (Berl) 1996;124:226-30.
41. Vercoulen JHMM, Swanink CMA, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996;347:858-61.
42. Hickie I, Wilson A, Wright J. A randomised, double blind placebo controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry 2000;61:643-8.
43. Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999;353:455-8.
44. McKenzie R, O'Fallon A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial. JAMA 1998;280:1061-6.
45. Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998;158:908-14.
46. Rowe P, Calkins H, DeBusk K, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: A randomized controlled trial. JAMA 2001;285:52-9.
47. Snorrason E, Geirsson A, Stefansson K. Trial of a selective acetylcholinesterase inhibitor, galanthamine hydrobromide, in the treatment chronic fatigue syndrome and related disorders. J Chronic Fatigue Syndr 1995;2:2-3.
48. Tiev KP, Cabane J, Imbert JC. Treatment of chronic postinfectious fatigue: Randomized double-blind study of two doses of sulbutiamine (400-600 mg/day) versus placebo. Rev Med Interne 1999;20:912-8.
49. Moorkens O, Wynants H, Abs R. Effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study. Growth Horm IGF Res 1998;8:131-3.
50. Forsyth LM, Preuss HG, MacDowell AL, et al. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol 1999;82:185-91.
51. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome: A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999;99:112-6.
52. Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand 1990;82:209-16.
53. Cox IM, Campbell MJ, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991;337:757-60.
54. Kaslow JE, Rucker L, Onishi R. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 1989;149:2501-3.
55. Stewart W, Rowse C. Supplements help ME says Kiwi study. J Alternat Complement Med 1987;5:19-20, 2.
56. Field TM, Sunshine W, Hernandez Reif M, et al. Massage therapy effects on depression and somatic symptoms in chronic fatigue syndrome. J Chronic Fatigue Syndr 1997;3:43-51.
57. Awdry R. Homeopathy may help ME. Int J Alternat Complement Med 1996;14:12-6.
58. Weatherley-Jones E, Thomas K, Nicholl J. Chronic fatigue syndrome: is homeopathic treatment worthwhile? A randomised, controlled trial of individualised treatment vs placebo. Proceedings of the ISHTAC Conference, Philadelphia, 2001.
59. Teitelbaum JE, Bird B, Greenfield RM, et al. Effective treatment of chronic fatigue syndrome and fibromyalgia: a randomized, double-blind, placebo-controlled, intent-to-treat study. J Chronic Fatigue Syndr 2001;8:3-28.
60. Chalder T. Family focused cognitive behaviour therapy for adolescents with chronic fatigue syndrome: a randomised controlled trial. Available from: http://www.update-software.com/nrr/ CLIBINET.EXE?A=1&U=1001&P=10001 (accessed 23 April 2002).